Panitumumab - PDFSEARCH.IO - Document Search Engine

Panitumumab
Results: 70

#	Item
41	Pharmawire:Diagnostic companies developing KRAS tests likely to see first impact of comparative effectiveness, industry experts say Add to Reading List Source URL: cabig.cancer.gov Language: English - Date: 2011-01-10 11:43:09 Bristol-Myers Squibb Cetuximab Genomics KRAS Personalized medicine Biomarker Panitumumab Colorectal cancer Roche Diagnostics Medicine Biology Pharmacology
42	Attachment A August 3, 2009 Amgen USA Inc. (Amgen) is making an adjustment to its PHS pricing for three Vectibix® (panitumumab) NDCs for the 2nd and 3rd quarters of[removed]PHS entities that purchased Vectibix® during th Add to Reading List Source URL: www.hrsa.gov - Date: 2012-10-04 17:58:42
43	Microsoft Word - FDA Letter_RxDrugLabeling_March2013 Add to Reading List Source URL: www.amp.org Language: English - Date: 2013-03-22 09:34:16 Food and Drug Administration Bristol-Myers Squibb Cetuximab Chemical pathology KRAS Center for Drug Evaluation and Research Panitumumab Pathology Medical laboratory scientist Medicine Health Pharmacology
44	Microsoft PowerPoint - Correlative Studies Analyses 2011 FINAL SLIDES.ppt [Compatibility Mode] Add to Reading List Source URL: www.kgh.on.ca Language: English - Date: 2011-12-14 11:35:08 Biomarker KRAS Colorectal cancer Panitumumab Medicine Bristol-Myers Squibb Cetuximab
45	2014 REPORT ON THE STATE OF THE ART OF RARE DISEASE ACTIVITIES IN EUROPE PART IV: EUROPEAN MEDICINES AGENCY ACTIVITIES AND OTHER EUROPEAN ACTIVITIES IN THE FIELD OF RARE DISEASES Add to Reading List Source URL: ec.europa.eu Language: English - Date: 2014-09-05 08:59:49 Clinical research Pharmaceutical industry European Medicines Agency Pharmacy Orphan drug Pharmacovigilance Committee for Medicinal Products for Human Use EMA Panitumumab Pharmaceutical sciences Pharmacology Health
46	Bringing together evidence generation and evidence synthesis to improve colon cancer genetic testing and treatment decisions Presented by: Katrina Goddard, PhD Center for Health Research, Kaiser Permanente Northwest, Add to Reading List Source URL: www.fda.gov Language: English KRAS Panitumumab Health Pharmacogenomics Medicine Bristol-Myers Squibb Cetuximab Kaiser Permanente
47	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Vectibix safely and effectively. See full prescribing information for Vectibix. ---------------------DOSAGE FORMS AN Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2012-08-20 14:33:43 Chemotherapy Amgen Colorectal cancer Adverse effect FOLFOX Cetuximab Medicine Panitumumab KRAS
48	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Vectibix safely and effectively. See full prescribing information for Vectibix. ---------------------DOSAGE FORMS AN Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2013-04-01 15:23:39 Chemotherapy Amgen Colorectal cancer Adverse effect FOLFOX Cetuximab Medicine Panitumumab KRAS
49	Addressograph Cancer genetics laboratory phone[removed] #2084 KRAS TEST REQUEST FOR METASTATIC COLORECTAL CANCER Add to Reading List Source URL: www.bccancer.bc.ca Language: English - Date: 2014-03-23 07:09:31 Gastrointestinal cancer Pathology KRAS Chemotherapy regimens Colorectal cancer Panitumumab Metastasis Cancer Medical laboratory Medicine Bristol-Myers Squibb Cetuximab
50	PANITUMUMAB (VECTIBIX) ADMINISTRATION GUIDELINES Add to Reading List Source URL: www.albertahealthservices.ca Language: English - Date: 2013-10-28 12:12:43 Bristol-Myers Squibb Cetuximab Panitumumab KRAS Colorectal cancer Magnesium Electrolyte disturbances Epidermal growth factor receptor Mucositis Medicine Chemistry Matter